Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation

Pediatr Blood Cancer. 2007 Dec;49(7):1000-4. doi: 10.1002/pbc.20700.

Abstract

We report a 3-year-old boy with a malignant triton tumor (MTT) involving the left masticator space with local invasion and regional lymph node metastasis. Family history and detection of a novel germline TP53 mutation confirmed his diagnosis of Li Fraumeni syndrome (LFS). MTT has not been previously described in association with LFS. This case along with a comprehensive review of the literature, illustrate the importance of both somatic and germline TP53 mutations in the pathogenesis MTT. The tumor could not be resected and he was successfully treated with intensive induction chemotherapy, irradiation, and high-dose chemotherapy with autologous stem cell transplantation.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child, Preschool
  • Combined Modality Therapy
  • Follow-Up Studies
  • Germ-Line Mutation*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Li-Fraumeni Syndrome / diagnosis
  • Li-Fraumeni Syndrome / genetics*
  • Li-Fraumeni Syndrome / therapy
  • Male
  • Nerve Sheath Neoplasms / diagnosis
  • Nerve Sheath Neoplasms / genetics*
  • Nerve Sheath Neoplasms / therapy
  • Nose Neoplasms / diagnosis
  • Nose Neoplasms / genetics*
  • Nose Neoplasms / therapy
  • Pedigree
  • Tomography, X-Ray Computed
  • Transplantation, Autologous
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • Tumor Suppressor Protein p53